Lausanne, Switzerland · Founded 2017 · Privately Held (backing)
Operator of a precision therapeutics company intended to discover and develop tissue and cell-selective genomic medicines for fibrotic diseases. HAYA Therapeutics is based in Lausanne, Switzerland and was founded in 2017. Its last reported valuation was $115 million in Apr 2025. It has raised $101 million.
Last reported valuation
$115.5M
Oct 2026
Priced at
—
Total raised
$101.0M
Last round
—
Cap table — not yet on record
HAYA Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of HAYA Therapeutics with a free account
·The complete investor list: 18 names
·Watch HAYA Therapeutics: the Monday email on marks, rounds and moves
